ABT-SLV187
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABT-SLV187, covering 2016-03-15 to 2021-05-12. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications [Phase 3]